# Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)

> **NCT00194922** · PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 35 (actual)

## Conditions studied

- Irritable Bowel Syndrome (IBS)

## Interventions

- **DIETARY_SUPPLEMENT:** E. Coli Strain M17 Probiotic

## Key facts

- **NCT ID:** NCT00194922
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2008-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00194922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00194922, "Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00194922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*